Galderma Laboratories, L.P.
Dallas, TX Part of Nestle Purina Petcare Co
- UEI
- MNX4XY6QXEL3
- CAGE
- 00ZY4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Corporate family
-
-
Parent
Nestle Purina Petcare Co · St. Louis, MO
FJQPWJT5PLQ9
-
Parent
Nestle Purina Petcare Co · St. Louis, MO
FJQPWJT5PLQ9
- SAM.gov registration date
- Physical address
- 2001 Ross Ave 16th Floor, Dallas, TX 75201, USA
- Website
- galderma.com
- Founded
- 1981
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Consumer Discretionary
- Consumer Durables & Apparel
- Consumer Goods
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $334,960 |
| FY2025 | $123,736 |
| FY2024 | $12,253 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $334,960 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nemluvio 30 MG | Veterans Integrated Service Network 5 (VHA) | $31,800 | |
| Nemluvio 30 MG | Veterans Integrated Service Network 5 (VHA) | $16,960 | |
| Emergency nemluvio | Veterans Integrated Service Network 22 (VHA) | $50,880 | |
| Nemluvio 30 MG | Veterans Integrated Service Network 5 (VHA) | $31,800 | |
| Nemluvio 30 MG | Veterans Integrated Service Network 5 (VHA) | $42,400 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| CSL Behring L.L.C. | King of Prussia, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Amneal Pharmaceuticals Of New York, LLC | Medford, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Botanix SB Inc. | Phoenix, AZ | 325412 Pharmaceutical Preparation Manufacturing |
| Argenx US, Inc. | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
| United Therapeutics Corp | Silver Spring, MD | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Galderma Laboratories, L.P., a foreign-owned pharmaceutical manufacturer based in Dallas, Texas, supplies injectable specialty pharmaceuticals to the Department of Veterans Affairs as a prime contractor exclusively through the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with no subcontracting activity across its federal footprint. The company is a child entity of Nestle Purina Petcare Co and operates as a for-profit limited liability partnership.
Galderma's federal business centers narrowly on a single product line—Nemluvio (nemolizumab) 30 mg injectable formulations and related Nemolizumab variants supplied to VA regional networks. Recent awards reflect firm fixed-price delivery orders and purchase orders ranging from $3,063 to $50,880 per transaction, with performance occurring in Carrollton, Texas or Dallas, Texas. Representative 2026 work includes a $50,880 emergency supply delivery order to Veterans Integrated Service Network 22 (ultimate completion July 2027), a $46,697 order to VISN 5 (September 2025), a $31,800 order to VISN 5 (September 2026), and a $33,920 order to VISN 21 for 16 units of Nemolizumab 30 mg injectable pens (October 2025). All awards carry no set-aside designation and operate under firm fixed-price terms with short performance windows typical of pharmaceutical procurement cycles.
Customer concentration is extreme and concentrated within VA regional networks. The top five VISNs account for 81% of award count, but potential-value concentration is dominated by a single outlier: VISN 12 anchors three awards worth $271.3 million combined potential value, representing 99.8% of the vendor's total potential value, while the remaining 24 awards across other VISNs total $422 thousand. VISN 5 places the highest award frequency (10 awards, $322 thousand combined potential value), whereas VISN 12's three awards dwarf all other customer relationships by two orders of magnitude. This structure reflects a mix of recurring small-volume regional pharmaceutical orders and at least one large-value supply commitment through VISN 12.
All 27 prime awards sit under the Pharmaceuticals and Drugs GSA schedule; 14 task orders carry $422 thousand combined potential value. NAICS coding shows Pharmaceutical Preparation Manufacturing (22 awards) and Surgical Appliance and Supplies Manufacturing (5 awards) across the footprint, with PSC coding dominated by Drugs and Biologicals (21 awards).
Activity has grown in recent years—three awards in 2016 and 2017, four in 2024, six in 2025, and seven through September 2026. Only one award (worth $51 thousand) faces ultimate completion within the next twenty-four months, presenting minimal recompete exposure in that window. The company has maintained federal contractor registration since February 2002 and has worked exclusively with the VA across its visible federal portfolio, with no awards from other agencies or defense customers.
Quick answers
Is Galderma Laboratories, L.P. registered in SAM.gov?
Yes. Galderma Laboratories, L.P.'s SAM.gov registration is active through December 24, 2026.
What is Galderma Laboratories, L.P.'s CAGE code?
Galderma Laboratories, L.P.'s CAGE code is 00ZY4, and its Unique Entity ID (UEI) is MNX4XY6QXEL3.
Which contract vehicles does Galderma Laboratories, L.P. hold?
Galderma Laboratories, L.P. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Galderma Laboratories, L.P. received in federal contracts?
Federal contracts obligated $123,736 to Galderma Laboratories, L.P. in fiscal year 2025 and $470,949 in fiscal years 2023 through 2027.
How does Galderma Laboratories, L.P. rank among federal contractors?
Galderma Laboratories, L.P. ranked #30 in PSC 3650 in FY2025.
What is Galderma Laboratories, L.P.'s most recent federal award?
Galderma Laboratories, L.P.'s most recent federal contract award is Nemluvio 30 MG (36C24526N0882), from Veterans Integrated Service Network 5 (VHA), on September 29, 2026.
On GovTribe
See Galderma Laboratories, L.P.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors